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A joint analysis of influenza-
associated hospitalizations and 
mortality in Hong Kong, 1998–2013
Peng Wu1, Anne M. Presanis2, Helen S. Bond1, Eric H. Y. Lau  1, Vicky J. Fang1 & Benjamin J. 
Cowling  1
Influenza viruses may cause severe human infections leading to hospitalization or death. Linear 
regression models were fitted to population-based data on hospitalizations and deaths. Surveillance 
data on influenza virus activity permitted inference on influenza-associated hospitalizations and 
deaths. The ratios of these estimates were used as a potential indicator of severity. Influenza was 
associated with 431 (95% CrI: 358–503) respiratory deaths and 12,700 (95% CrI: 11,700–13,700) 
respiratory hospitalizations per year. Majority of the excess deaths occurred in persons ≥65 y of age. 
The ratios of deaths to hospitalizations in adults ≥65 y were significantly higher for influenza A(H1N1) 
and A(H1N1)pdm09 compared to A(H3N2) and B. Substantial disease burden associated with influenza 
viruses were estimated in Hong Kong particularly among children and elderly in 1998–2013. Infections 
with influenza A(H1N1) was suggested to be more serious than A(H3N2) in older adults.
Influenza viruses circulate around the world each year, causing infections and disease in all age groups1. A small 
fraction of influenza virus infections are severe, requiring hospitalization, and some infections can be fatal. Apart 
from deaths caused by primary viral pneumonia, influenza virus infections can also lead to secondary bacterial 
infections1, and can exacerbate underlying medical conditions such as cardiovascular disease2. One approach to 
quantify the disease burden of influenza is to estimate the incidence rate of hospitalizations of patients with severe 
acute respiratory illnesses and laboratory-confirmed influenza virus infections, and the incidence of severe out-
comes in those patients, along with population denominators3. However, this can underestimate the full burden 
of influenza because not all patients with severe outcomes after influenza virus infections present for medical 
attention or are tested for influenza virus, and because even among those that are tested some influenza virus 
infections will not be laboratory confirmed, particularly if there is a delay between infection and the exacerbation 
of an underlying condition4.
The preferred approach to quantify the full disease burden of influenza in a population is indirect estima-
tion using statistical modeling5. In this ecological approach, a time series of hospitalization or mortality rates is 
regressed against a variable indicating influenza virus activity over time in the same population. This statistical 
model can then be used to infer the proportion of hospitalizations or deaths associated with influenza6. Statistical 
models can be fitted for time series of hospitalizations or deaths from specific causes, or all causes.
In the present study, we used hospitalization data, mortality data and influenza surveillance data from 
January 1998 through to June 2013 to infer the burden of influenza-associated hospitalizations and deaths in 
Hong Kong before, during and after the 2009–10 influenza A(H1N1)pdm09 pandemic. This updates our previous 
estimates of influenza-associated mortality from 1998–20097 and in 2010–118, as well as published estimates of 
influenza-associated hospitalizations in Hong Kong from 1996–20009, 2004–1010, and 2005–1011, 12. In addition 
to estimating influenza-associated hospitalizations and deaths, we also examined the ratios of deaths to hospitali-
zations as a novel approach to indicate the potential relative severity of infections with different types/subtypes of 
influenza virus in a Bayesian framework.
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Methods
Sources of data. Individual data on deaths were obtained from the Census and Statistics Department of 
Hong Kong. Each record included age, sex, date of death, and cause. Weekly data on hospital admissions were col-
lected from the Hospital Authority for patients admitted to all local public hospitals, which cover approximately 
90% of hospital bed days in Hong Kong13. Hospital admissions were aggregated by age, sex, date of admission, and 
primary diagnosis coded by the International Classification of Diseases, Ninth Revision, Clinical Modification 
(ICD-9-CM) including respiratory diseases (460–519), cardiovascular diseases (390–459), and all causes (001-
999, V01-V91, E000-E999).
Influenza surveillance in local private outpatient clinics is coordinated by the Centre for Health Protection 
in Hong Kong, who report weekly data on the rates of influenza-like-illnesses (ILI, defined as fever >38 °C with 
cough and/or sore throat) per 1000 outpatient consultations. Age-specific ILI rates are not reported. Laboratory 
data on influenza virus detections by type/subtype and the total number of specimens submitted for diagnostic 
testing or for surveillance purposes are reported by the Public Health Laboratory Services. We combined out-
patient surveillance data and laboratory detections into four time-series of proxy measures for influenza virus 
activity in the community, denoted as ILI+ proxies, by multiplying the rate of ILI consultations per 1000 consul-
tations with the proportion of specimens testing positive for each type/subtype of influenza. We constructed ILI+ 
proxies for pre-pandemic influenza A(H1N1), influenza A(H3N2), influenza A(H1N1)pdm09, and for influenza 
B. We previously reported that this ILI+ proxy for influenza A(H1N1)pdm09 was the closest linear correlate of 
influenza A(H1N1)pdm09 virus infections in the general community10. We used the weekly hospitalization rate 
of acute bronchiolitis associated with respiratory syncytial virus (RSV) (ICD-9: 466.11) in children <1 year of age 
as the proxy for RSV activity14. Meteorological data including daily mean temperature and relative humidity were 
obtained from the Hong Kong Observatory.
Statistical analysis. We applied linear regression models to investigate the association between influenza 
activity, as indicated by the ILI+ proxies, and weekly hospitalization rates or mortality rates. We used linear 
regression, assuming an additive relation between influenza activity and mortality rates or hospitalization rates, 
which might be preferred to models assuming a multiplicative increase in the outcomes associated with additive 
changes in influenza activity6–8. The models also included temperature, absolute humidity, and RSV activity using 
the RSV proxy described above. Another covariate was included into the models for mortality rates to account for 
the impact of the transition of coding system (ie, from ICD-9 to ICD-10) for mortality data, in Hong Kong since 
20017. We also included a covariate into the models for hospitalization rates to account for the impact of public 
holidays on hospital admissions. We excluded the time period when the outbreaks of severe acute respiratory syn-
drome (SARS) were reported from the analysis, i.e. from 11 February 2003 when the World Health Organization 
first received reports from China on an outbreak of acute respiratory syndrome occurred in Guangdong province, 
to 28 May 2004 when the Hong Kong government lowered the Alert Level of SARS response system.
The linear regression models (Supplementary Information) for estimation of influenza-associated excess 
mortality and hospitalization were fitted to the data in a Bayesian framework using Markov Chain Monte 
Carlo methods15. We chose to use the Bayesian framework for our analyses because this framework allows for 
propagation of uncertainty from the data through to all parameters and functions of parameters, including 
specifically the ratios of excess deaths to excess hospitalizations, and the comparison of these ratios between 
different influenza types and subtypes. It would be much more challenging to obtain uncertainty intervals for 
these ratios, and ratios-of-ratios, with an analysis done in a frequentist framework. Previous analyses of excess 
influenza-associated mortality have generally been done in frequentist frameworks, but one recent study did use 
a Bayesian framework16.
In each model, posterior distributions of the model parameters were estimated based on sampling from 
three Markov chains, each of which had 2000 iterations and a burn-in period of 500 iterations (Supplementary 
Information). Convergence was assessed using the potential scale reduction statistic17. Excess hospitalizations and 
deaths were estimated by comparing the predicted hospitalization and death rates under the model with ILI+ 
proxies set to zero with the predicted rates with ILI+ proxies set to their observed values5, 7. We estimated 95% 
credibility intervals for these estimates based on the samples drawn from the posterior distributions. Estimates of 
the ratios of deaths to hospitalizations, and comparisons of these ratios, were also based on the posterior samples. 
All statistical analyses were done in R version 3.2.3 (R Foundation for Statistical Computing, Vienna, Austria) 
and the ‘rstan’ package.
Results
We studied a total of 583,000 deaths and 18.9 million hospitalizations recorded from 1 January 1998 through 9 
June 2013, with the population of Hong Kong increasing from 6.52 million persons in 1998 to 7.18 million in 
2013. During the study period of 15.5 years, influenza viruses circulated for prolonged periods in most years, with 
two distinct epidemics in some years such as 2000, 2003 and 2008, and prolonged epidemics in other years such 
as 2002 and 2004 (Fig. 1).
Using regression analysis, we estimated that influenza was associated with 6.27 (95% credibility interval (CrI): 
5.21, 7.32) excess respiratory deaths per 100,000 persons per year, and 184 (95% CrI: 170, 199) excess respiratory 
hospitalizations per 100,000 persons per year (Table 1). This corresponded to an average of 431 (95% CrI: 358, 
503) excess respiratory deaths per year and an average of 12,700 (95% CrI: 11,700, 13,700) excess respiratory hos-
pitalizations per year, which were 1.14% (85% CrI: 0.95%, 1.34%) of all deaths and 1.04% (95% CrI: 0.96%, 1.12%) 
of all hospitalizations over the study period, respectively.
Rates of influenza-associated excess respiratory mortality were much greater in adults ≥65 y than in all other 
age groups, while rates of influenza-associated respiratory hospitalizations had a U-shaped relation with age, 
being greatest in those <1 y and ≥65 y, and lowest in those 16–44 y. Whereas 96% of excess respiratory deaths 
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were estimated to occur in persons ≥65 y, only 57% of excess respiratory hospitalizations were estimated to occur 
in this age group.
When examining the contribution of different types and subtypes of influenza virus, we found that influenza 
A(H3N2) had the greatest impact, contributing around half of the excess respiratory mortality and respiratory 
hospitalizations on average, with influenza B contributing the second largest average during the study period of 
15.5 years. Influenza A(H1N1)pdm09 was associated with the highest excess respiratory hospitalization rate in 
older children 6–15 y and young adults 16–44 y among all types/subtypes of influenza virus (Table 1).
Figure 1. Weekly influenza virus activity in Hong Kong from 1998 through 2013, measured by ILI+ proxies 
defined for each influenza type/subtype as the product of the weekly proportion of outpatient consultations 
associated with influenza-like-illness in sentinel clinics and the weekly proportions of laboratory specimens 
testing positive for influenza A(H1N1), A(H3N2), A(H1N1)pdm09 and B viruses respectively.
<1 year
1–5 
years
6–15 
years 16–44 years
45–64 
years ≥65 years
All 
ages
Mean (95% credibility interval) (per 100,000 person-years)
Death
All influenza 2.2 (−0.2, 5.0)
−0.2 
(−1.0, 
0.5)
0.1 
(−0.1, 
0.4)
−0.1 (−0.2, 0.1) 1.8 (1.1, 2.5)
48.7 
(40.4, 
56.5)
6.3 (5.2, 
7.3)
A(H1N1 1.2 (−0.3, 2.8)
0.4 
(−0.1, 
0.8)
0.1 
(−0.1, 
0.2)
0.0 (−0.1, 0.1) 0.5 (0.0, 1.0)
9.2 (4.0, 
14.1)
1.3 (0.7, 
2.0)
A(H3N2) 1.5 (0.0, 3.4)
−0.3 
(−0.8, 
0.2)
0.0 
(−0.2, 
0.2)
0.0 (−0.1, 0.1) 1.0 (0.5, 1.4)
26.5 
(21.1, 
31.9)
3.2 (2.6, 
3.9)
B
−0.1 
(−1.9, 
1.9)
−0.1 
(−0.6, 
0.5)
0.0 
(−0.2, 
0.2)
−0.1(−0.2, 0.1)
0.3 
(−0.2, 
0.9)
11.3 
(5.0, 
17.2)
1.4 (0.6, 
2.3)
A(H1N1)pdm09
−0.5 
(−2.5, 
1.4)
−0.5 
(−1.0, 
0.1)
0.1 
(−0.1, 
0.3)
0.1 (−0.1, 0.2)
0.4 
(−0.1, 
0.9)
13.1 
(6.4, 
19.4)
2.0 (1.2, 
3.0)
Hospitalization
All influenza
1260.0 
(1124.0, 
1410.6)
692.0 
(627.8, 
760.3)
165.6 
(148.4, 
183.1)
15.5 (11.0, 19.9)
68.4 
(60.6, 
76.4)
847.2 
(775.2, 
913.2)
184.0 
(167.0, 
198.8)
A(H1N1)
190.7 
(112.4, 
260.5)
87.0 
(41.7, 
127.7)
25.3 
(16.6, 
35.3)
2.7 (−0.3, 5.6) 7.6 (2.7, 12.4)
51.3 
(7.6, 
89.4)
17.3 (8.7, 
26.4)
A(H3N2)
648.7 
(533.4, 
738.0)
332.3 
(288.3, 
382.4)
49.1 
(38.4, 
60.6)
7.5 (4.2, 10.7)
36.2 
(30.9, 
41.0)
502.5 
(454.0, 
548.8)
97.9 
(88.5, 
106.4)
B
379.6 
(287.4, 
468.7)
219.9 
(161.1, 
271.3)
62.9 
(50.3, 
76.9)
2.0 (−1.5, 5.7)
18.7 
(12.8, 
24.8)
276.0 
(227.5, 
325.4)
57.2 
(45.0, 
68.8)
A(H1N1)pdm09
289.6 
(187.8, 
410.4)
249.5 
(197.7, 
301.1)
117.1 
(103.5, 
130.7)
13.3 (9.5, 16.9)
26.6 
(20.7, 
32.4)
99.8 
(50.4, 
150.6)
53.8 
(42.0, 
66.8)
Table 1. Average annual influenza-associated excess mortality and hospitalization rates from respiratory 
diseases by type and subtype of virus in different age groups of Hong Kong population from January 1998 
through June 2013.
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We found that the proportions of cause-specific mortality and hospitalization attributable to influenza 
varied across different types/subtypes of influenza virus. The estimated contribution of influenza viruses to 
all-cause mortality and all-cause hospitalizations was approximately double the impact on respiratory mortality 
and hospitalizations respectively (Table 2). Influenza A(H3N2) was associated with approximately half of the 
influenza-attributable excess mortality and excess hospitalization across different causes of disease. Influenza B 
had a greater contribution to the excess all-cause hospitalizations (177 per 100,000 persons per year) than that 
to excess cardiorespiratory hospitalizations (75 per 100,000 persons per year), while cardiorespiratory diseases 
accounted for majority of excess hospitalizations for different subtypes of influenza A viruses (Table 2). Seasonal 
influenza A(H1N1) was generally associated with the lowest excess hospitalizations among the four types/sub-
types of virus while the estimated excess mortality was largely similar to influenza B and A(H1N1)pdm09 across 
different causes of disease classifications.
We estimated that the ratio of excess respiratory deaths to excess respiratory hospitalizations was 34.2 (95% 
CrI: 27.6, 41.1) deaths per 1,000 hospitalizations in all ages for influenza viruses overall. In other words, for every 
1,000 estimated excess respiratory hospitalizations associated with influenza, we estimated that there were around 
34.2 influenza-associated excess respiratory deaths in Hong Kong. When stratifying analyses by age, the estimated 
ratios were unstable with wide credibility intervals in most age groups because of the low numbers of excess 
deaths, but we were able to estimate ratios for adults 45–64 y and ≥65 y. The ratios were smaller for 45–64 y, with 
an average of 26.5 (95% CrI: 15.6, 39.3) excess respiratory deaths for every one thousand excess respiratory hospi-
talizations in this age group, compared to 58.8 (95% CrI: 49.1, 69.1) excess respiratory deaths for every thousand 
excess respiratory hospitalizations in persons ≥65 y.
Estimates of excess death in persons ≥65 y allowed us to compare these ratios of deaths to hospitalizations 
between the different influenza types/subtypes. In this age group, the ratio of deaths to hospitalizations for 
H1N1pdm09 was a factor of 2.7 (95% CrI: 1.1, 5.9) higher than the ratio of deaths to hospitalzations for H3N2 
(Table 3). Similarly, the hospitalization to death ratio was significantly higher for seasonal H1N1 compared to 
H3N2 by a factor of 3.6 (95% CrI: 1.4, 14.5), and was significantly higher for H1N1pdm09 compared to influenza 
B by a factor of 3.8 (95% CrI: 1.2, 10.0), and for seasonal H1N1 compared to influenza B by a factor of 5.8 (95% 
CrI: 1.4, 25.8). There was no significant difference in the death to hospitalization ratio for influenza B compared to 
H3N2 (ratio 0.8, 95% CrI: 0.4, 1.4) and for H1N1pdm09 compared to seasonal H1N1 (ratio 1.8, 95% CrI: 0.4, 7.5). 
We were unable to evaluate similar ratios for other age groups because of the greater uncertainty in the estimated 
death-to-hospitalization ratios.
Discussion
In our study, we estimated that a substantial burden of morbidity and mortality in Hong Kong population could 
be attributed to influenza virus infections during our study period of 1998–2013, including around 1.0% of all 
hospitalizations and 1.1% of all deaths. The two extremes of age, 0–5 years and ≥65 years, were most vulner-
able to severe respiratory influenza virus infections. However the highest rates of excess respiratory mortality 
occurred in older adults ≥65 years accounting for around 1.4% of all-cause deaths in that age group, while 
influenza-associated excess mortality in children was close to zero, as was also shown in a recent study conducted 
in the United Kingdom18. The higher impact of influenza on mortality among the elderly might be associated 
with a higher prevalence of underlying medical conditions in this segment of the population19, 20. The estimates of 
A(H1N1) A(H3N2) B
A(H1N1)
pdm09 All influenza
Mean (95% credibility interval) (per 100,000 person-years)
Death
All causes 2.3 (0.8, 3.8) 6.9 (5.4, 8.5) 2.4 (0.5, 4.5) 2.2 (−0.0, 4.2) 11.7 (9.2, 14.3)
Cardiovascular & 
respiratory 1.6 (0.6, 2.7) 4.9 (3.6, 6.0)
1.1 (−0.2, 
2.4) 1.8 (0.4, 3.1) 7.7 (6.0, 9.6)
Respiratory 1.3 (0.7, 2.0) 3.2 (2.6, 3.9) 1.4 (0.6, 2.3) 2.0 (1.2, 3.0) 6.3 (5.2, 7.3)
Pneumonia and 
influenza 0.9 (0.4, 1.4) 1.8 (1.2, 2.3)
0.8 (0.1, 
1.5) 1.5 (1.0, 2.2) 3.7 (2.8, 4.6)
Hospitalization
All causes −3.2 (−57.7, 44.4)
83.0 (24.9, 
136.2)
177.2 
(121.0, 
234.3)
93.9 (36.4, 
152.5)
284.9 (198.6, 
357.8)
Cardiovascular & 
respiratory 19.5 (7.2, 31.0)
101.2 (89.5, 
113.9)
75.2 (60.0, 
90.7)
55.0 (37.9, 
69.9)
207.5 (186.2, 
227.8)
Respiratory 17.3 (8.7, 26.4) 97.9 (88.5, 106.4)
57.2 (45.0, 
68.8)
53.8 (42.0, 
66.8)
184.0 (170.0, 
198.8)
Pneumonia and 
influenza 10.0 (5.6, 13.5)
38.4 (34.0, 
43.3)
17.0 (11.8, 
22.6)
38.2 (32.9, 
43.6)
74.3 (67.6, 
80.7)
Table 2. Average annual influenza-associated excess mortality and hospitalization rates from all causes, 
cardiovascular and respiratory diseases and pneumonia and influenza by virus type and subtype in Hong Kong 
population from January 1998 through June 2013.
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the highest excess respiratory hospitalization in young children were largely consistent with findings from other 
studies of influenza-associated hospital admissions in Hong Kong21, 22.
Influenza A(H3N2) is generally found to cause the greatest impact among all influenza types/subtypes, 
because of its particularly high impact in older adults5, 7. The impact of each type/subtype will vary from year 
to year because of different patterns in circulation, but our study over 15.5 years covered a broad timespan with 
more than one influenza epidemic in most years (Fig. 1). Our results indicated that influenza A(H3N2) consist-
ently contributed around half of the overall excess hospitalizations across different age groups except for among 
children 6–15 y in which most influenza-associated excess hospitalizations were due to H1N1pdm09 during the 
study period. The relatively higher estimates of excess hospital admission associated with A(H1N1)pdm09 com-
pared to seasonal A(H1N1) perhaps implied a higher disease burden introduced by A(H1N1)pdm09 since the 
seasonal influenza A(H1N1) virus was replaced by A(H1N1)pdm09 after 2009.
In persons ≥65 y, we estimated that for every 1000 influenza-associated excess hospitalizations there were 58.8 
(95% CrI: 49.1, 69.1) deaths. Because not every death would have necessarily been preceded by a hospitalization, 
we cannot interpret this estimate as a risk of death among older adults hospitalized with influenza. Nevertheless, 
the estimate is well within the range of 50 to 100 deaths per 1000 hospitalizations that would have been antici-
pated based on analyses of cohorts of hospitalized older adults in which the risk of mortality is typically around 
4–8%23–25.
We compared the estimates of excess respiratory death to excess respiratory hospitalization ratios for persons 
≥65 y between influenza types and subtypes, and found that the ratios were significantly higher for pre-pandemic 
influenza A(H1N1) and A(H1N1)pdm09 viruses, compared to influenza A(H3N2) and B (Table 3). While 
A(H1N1) viruses tended to have lower overall impact in older adults (Table 1), our analysis on excess death to 
hospitalization ratios suggests the possibility that influenza A(H1N1) virus infections are relatively more severe, 
on a per-infection basis, than influenza A(H3N2) and B virus infections. This hypothesis is supported by analyses 
of hospitalized patients in Hong Kong and the United States, where the risk of complications was higher for influ-
enza A(H1N1)pdm09 virus infections compared to seasonal influenza virus infections, after adjusting for age23, 26.
An advantage of conducting these analyses within a Bayesian framework was the availability of uncertainty 
ranges for ratios of estimates, such as death to hospitalization ratios. In a frequentist framework, it can be chal-
lenging to assess the uncertainty of estimates based on combinations of other parameters. The Bayesian frame-
work for this analysis might also be extended to allow timely estimation of disease impact in very recent years 
before the availability of hospitalization and mortality data, by using most recent data to update the posterior 
distributions of parameter estimates from prior years.
There are a number of limitations to our work. First, hospital admission data collected from all the public hos-
pitals in Hong Kong were used to estimate influenza-associated excess respiratory hospitalizations, which might 
lead to an underestimation of excess respiratory hospitalizations because 90% of hospital admissions occurred 
in public hospitals in Hong Kong while data on the other 10% occurring in private hospitals are unavailable. 
Second, we estimated that there were very few excess respiratory deaths associated with influenza in children and 
younger adults, while excess hospitalization rates were low in older children and younger adults, precluding esti-
mation of death to hospitalization ratios for these age groups. Third, in this study we only estimated an averaged 
influenza-associated impact across age groups although other risk factors such as underlying medical conditions, 
pregnancy or previous vaccination history might potentially modify the impact from influenza on the population. 
Finally, we examined excess respiratory deaths and respiratory hospitalizations, which may underestimate the full 
burden of influenza because of its impact on other diseases such as cardiovascular diseases27, 28 or other diseases5, 
7. Previous studies have often estimated that the impact of influenza virus epidemics on all-cause mortality is 
around double or triple the impact on respiratory mortality5, 29, 30.
In conclusion, influenza viruses caused substantial excess respiratory hospitalizations particularly in chil-
dren and the elderly in Hong Kong in 1998–2013, while most influenza-associated excess respiratory deaths 
occurred in persons ≥65 y. Seasonal influenza A(H3N2) accounted for majority of the excess disease burden, 
Ratios of excess 
respiratory death to 
hospitalization
Relative ratios of 
excess respiratory 
death to 
hospitalization
Mean (95% 
credibility interval) 
(per 1,000 excess 
hospitalizations)
Mean (95% 
credibility interval)
All influenza 58.8 (49.1, 69.1) —
Influenza by type/subtype
 A(H3N2) 52.5 (40.6, 65.3) Reference
 A(H1N1) 193.8 (74.2, 754.5) 3.6 (1.4, 14.5)
 A(H1N1)pdm09 141.4 (57.6, 294.5) 2.7 (1.1, 5.9)
 B 41.7 (19.3, 68.2) 0.8 (0.4, 1.4)
Table 3. Ratios of the influenza-associated annual excess respiratory death rate to the excess respiratory 
hospitalization rate by virus type/subtype and relative ratios of excess respiratory death to hospitalization for 
influenza A(H1N1), A(H1N1pdm09) and B compared to influenza A(H3N2) in Hong Kong population ≥65 
years of age from January 1998 through June 2013.
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while our estimates of death to hospitalization ratios suggested that infections with seasonal influenza A(H1N1) 
and A(H1N1)pdm09 viruses might be more serious on average compared to other virus types/subtypes, in per-
sons ≥65 y. Further studies would be warranted to investigate the differential impact of influenza on particular 
segments of the population that might face a higher risk of severe disease following infection, such as pregnant 
women, and adults with underlying medical conditions including COPD or chronic heart diseases.
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